Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IMPLANTED BIOMATERIALS

Long-term viability through selective permeability

The cell-selective permeability of a retrievable microporous device encapsulating human therapeutic cells and implanted in the intraperitoneal space of mice provides long-term protection to the transplanted cells by dampening foreign-body responses and preventing the immune rejection of the graft.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells.

References

  1. Desai, T. & Shea, L. D. Nat. Rev. Drug Discov. 16, 338–350 (2017).

    Article  CAS  Google Scholar 

  2. Henry, R. R. et al. Diabetes 67 (Suppl. 1), 138–OR (2018).

  3. Bose, S. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0538-5 (2020).

  4. Salehi, S. & Reed, E. F. Curr. Opin. Organ Transplant. 20, 446–453 (2015).

    Article  CAS  Google Scholar 

  5. Anderson, J. M., Rodriguez, A. & Chang, D. T. Semin. Immunol. 20, 86–100 (2008).

    Article  CAS  Google Scholar 

  6. An, D. et al. Proc. Natl Acad. Sci USA 115, E263–E272 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthias von Herrath.

Ethics declarations

Competing interests

All authors are employed by Novo Nordisk, hold shares in the company and are involved in the company’s stem cell research and development.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coppieters, K., Winkel, L. & von Herrath, M. Long-term viability through selective permeability. Nat Biomed Eng 4, 763–764 (2020). https://doi.org/10.1038/s41551-020-0602-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-020-0602-1

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research